BLOG

X-ZELL Blog Episode 13

“X-ZELL fuses next-generation rare cell detection technology with Artificial Intelligence to catapult pathology into the digital age. The result is an accurate, affordable and scientifically proven method of screening small, 10mL blood samples for traces of...

X-ZELL Blog Episode 12

Two years ago, almost to the day, X-ZELL hit a milestone that many say separates the wheat from the chaff – the equally daunting and exhilarating leap from research to commercialisation. Under the watchful eye of the market, the cancer detection start-up has since...

X-ZELL Blog Episode 11

Artificial intelligence, 3D printing, driverless transportation – the innovation wheel has never spun as fast as today. Despite the much-cited Theranos effect – coined by Bloomberg to describe the painful aftermath of Elisabeth Holmes’ history-making blood analysis...

X-ZELL Blog Episode 10

Less than two years after starting the transition from local research company into global enterprise, X-ZELL is about to celebrate our biggest milestone yet – the long-anticipated world premiere of the X-ZELL Cryoimmunostaining™ Suite, to be held at MEDLAB 2019 in...

X-ZELL Blog Episode 9

Largely unnoticed by the general public, early prostate cancer detection recently rose to the very top of the European Parliament’s teeming agenda. Coinciding with the European Prostate Cancer Awareness Day (EPAD), the EU's law-making body invited policy makers,...

X-ZELL Blog Episode 8

In episode five of the new X-ZELL blog, our editorial team first shed a light on the growing controversy around the utility of multi-parametric magnetic resonance imaging (mpMRI) as a triage test to avoid unnecessary biopsy and improve diagnostic accuracy.Ranked one...

X-ZELL Blog Episode 7

Less than three months ago, in August 2018, X-ZELL CEO Dr Sebastian Bhakdi took to stage at the 19th Asia-Pacific Prostate Cancer Conference in Brisbane (Australia) to reveal an unexpected breakthrough in early cancer detection. Using a new platform technology capable...

X-ZELL Blog Episode 6

On 15 December 2017, a simple tweet started a scientific revolution that could change our very understanding of early cancer detection.Following years of research, X-ZELL used social media to share the first-ever image of a tumour-derived Circulating Endothelial Cell...

X-ZELL Blog Episode 5

The role of magnetic resonance imaging (MRI) as a tool to detect and stage clinically significant prostate cancer (csPCa) continues to cause controversy among the medical community.The 19th Asia-Pacific Prostate Cancer Conference (APCC) held in Brisbane last month...

X-ZELL Blog Episode 4

Friday, 24 August 2018, will go down as a decisive milestone in the history of X-ZELL Inc. – not just because we had the privilege of sharing our latest research with the global scientific community, but also because we had a chance to showcase just how perfectly our...

X-ZELL

FIGHTING CANCER,
ONE CELL AT A TIME.

© 2019 X-ZELL INC

Find Us

XZELL HQ